These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 19013345

  • 1. Candidemia in the critically ill patient.
    Picazo JJ, González-Romo F, Candel FJ.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology of candidemia in intensive care units.
    Bouza E, Muñoz P.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 4. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.
    Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM.
    Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056
    [Abstract] [Full Text] [Related]

  • 5. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
    Devlin RK.
    Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
    [Abstract] [Full Text] [Related]

  • 6. Invasive fungal infections in the intensive care unit.
    Vazquez JA.
    Semin Respir Crit Care Med; 2010 Feb; 31(1):79-86. PubMed ID: 20101550
    [Abstract] [Full Text] [Related]

  • 7. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrel M, Fraser VJ, Kollef MH.
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [Abstract] [Full Text] [Related]

  • 8. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
    Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME.
    Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
    [Abstract] [Full Text] [Related]

  • 9. Candida prophylaxis and therapy in the ICU.
    Echeverria PM, Kett DH, Azoulay E.
    Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.
    Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981
    [Abstract] [Full Text] [Related]

  • 11. To treat or not to treat--critically ill patients with candiduria.
    Hollenbach E.
    Mycoses; 2008 Sep 15; 51 Suppl 2():12-24. PubMed ID: 18721329
    [Abstract] [Full Text] [Related]

  • 12. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
    Benjamin DK, Ross K, McKinney RE, Benjamin DK, Auten R, Fisher RG.
    Pediatrics; 2000 Oct 15; 106(4):712-8. PubMed ID: 11015513
    [Abstract] [Full Text] [Related]

  • 13. [Candidemia in an intensive care unit].
    Adukauskiene D, Kinderyte A, Dambrauskiene A, Vitkauskiene A.
    Medicina (Kaunas); 2009 Oct 15; 45(5):351-6. PubMed ID: 19535880
    [Abstract] [Full Text] [Related]

  • 14. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, Sorrell TC.
    Crit Care Med; 2008 Jul 15; 36(7):2034-9. PubMed ID: 18552700
    [Abstract] [Full Text] [Related]

  • 15. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata.
    Blot S, Vandewoude K, Hoste E, Poelaert J, Colardyn F.
    J Hosp Infect; 2001 Apr 15; 47(4):308-13. PubMed ID: 11289775
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A.
    Mycoses; 2010 May 15; 53 Suppl 1():30-5. PubMed ID: 20433654
    [Abstract] [Full Text] [Related]

  • 17. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM, Skaar DJ, Ackerman BH.
    Pharmacotherapy; 1997 May 15; 17(3):538-48. PubMed ID: 9165556
    [Abstract] [Full Text] [Related]

  • 18. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults.
    McMullan R, Metwally L, Coyle PV, Hedderwick S, McCloskey B, O'Neill HJ, Patterson CC, Thompson G, Webb CH, Hay RJ.
    Clin Infect Dis; 2008 Mar 15; 46(6):890-6. PubMed ID: 18260751
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH, Guglielmo BJ.
    Expert Rev Anti Infect Ther; 2006 Feb 15; 4(1):137-49. PubMed ID: 16441215
    [Abstract] [Full Text] [Related]

  • 20. [Invasive fungal infection in critically ill patients].
    Garnacho-Montero J, Díaz-Martín A, Ruiz-Pérez De Piappón M, García-Cabrera E.
    Enferm Infecc Microbiol Clin; 2012 Jun 15; 30(6):338-43. PubMed ID: 22503211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.